Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

Clinical trial NCT01027364 · COMPLETED

Trial details

NCT number: NCT01027364
Sponsor: Bioverativ Therapeutics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Severe Hemophilia B

Start date: 2009-12-01
Primary completion: 2012-07-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.